Implication of different initial beta blockers on treatment persistence: atenolol vs new-generation beta blocker, a population-based study

摘要

AimPotential heterogeneity within the same class of drug in terms of persistence may lead to different clinical implications. Given that the increased risks of mortality and cardiovascular events are due, in part, to the lack of persistent use of antihypertensive medications, the objective of this study was to evaluate 1-year persistence of new-generation beta blockers compared to atenolol in antihypertensive treatment-naive patients.